SG Americas Securities LLC decreased its position in Plexus Corp. (NASDAQ:PLXS – Free Report) by 48.8% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 8,521 shares of the technology company’s stock after selling 8,112 shares during the period. SG Americas Securities LLC’s holdings in Plexus were worth $1,253,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Salomon & Ludwin LLC bought a new stake in Plexus in the third quarter valued at $30,000. Allworth Financial LP boosted its holdings in Plexus by 70.1% in the third quarter. Allworth Financial LP now owns 250 shares of the technology company’s stock valued at $36,000 after acquiring an additional 103 shares in the last quarter. Johnson Financial Group Inc. bought a new stake in Plexus in the third quarter valued at $72,000. EverSource Wealth Advisors LLC boosted its holdings in Plexus by 583.3% in the second quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company’s stock valued at $78,000 after acquiring an additional 490 shares in the last quarter. Finally, Smartleaf Asset Management LLC boosted its holdings in Plexus by 33.0% in the third quarter. Smartleaf Asset Management LLC now owns 806 shares of the technology company’s stock valued at $115,000 after acquiring an additional 200 shares in the last quarter. Institutional investors own 94.45% of the company’s stock.
Plexus Price Performance
Shares of NASDAQ:PLXS opened at $207.87 on Wednesday. The business has a 50-day simple moving average of $199.37 and a two-hundred day simple moving average of $167.93. The firm has a market cap of $5.57 billion, a price-to-earnings ratio of 32.33 and a beta of 0.75. Plexus Corp. has a fifty-two week low of $108.21 and a fifty-two week high of $220.17. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.75 and a current ratio of 1.59.
Insider Activity at Plexus
In other news, CFO Patrick John Jermain sold 2,321 shares of the company’s stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $201.12, for a total value of $466,799.52. Following the transaction, the chief financial officer directly owned 14,561 shares in the company, valued at approximately $2,928,508.32. This represents a 13.75% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Oliver K. Mihm sold 9,541 shares of the stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $201.40, for a total value of $1,921,557.40. Following the transaction, the chief operating officer directly owned 12,809 shares in the company, valued at $2,579,732.60. The trade was a 42.69% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 49,495 shares of company stock worth $10,009,836 in the last ninety days. Corporate insiders own 1.78% of the company’s stock.
Wall Street Analyst Weigh In
PLXS has been the topic of several recent analyst reports. Weiss Ratings upgraded shares of Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a report on Friday, March 6th. Zacks Research raised Plexus from a “hold” rating to a “strong-buy” rating in a research report on Friday, February 6th. Wall Street Zen lowered Plexus from a “buy” rating to a “hold” rating in a research report on Sunday, March 8th. Benchmark reissued a “buy” rating and set a $220.00 price objective on shares of Plexus in a research report on Monday, March 16th. Finally, Stifel Nicolaus raised their price objective on Plexus from $150.00 to $200.00 and gave the company a “hold” rating in a research report on Friday, January 30th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $194.20.
Check Out Our Latest Stock Analysis on Plexus
Plexus Company Profile
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Read More
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
